Article info

Download PDFPDF
Extended report
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs

Authors

  1. Correspondence to Professor Georg Schett, Department of Internal Medicine 3, Rheumatology and Immunology, University Clinic of Erlangen-Nuremberg, Erlangen; Ulmenweg 18, Erlangen 91054, Germany; georg.schett{at}uk-erlangen.de
View Full Text

Citation

Figueiredo CP, Bang H, Cobra JF, et al
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs

Publication history

  • Received January 31, 2016
  • Revised April 26, 2016
  • Accepted May 27, 2016
  • First published June 20, 2016.
Online issue publication 
January 10, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.